Promiliad Overview

  • Founded
  • 2002
  • Status
  • Private
  • Employees
  • 5
  • Latest Deal Type
  • Later Stage VC
  • Investors
  • 2

Promiliad General Information


Provider of a drug discovery platform intended to focus on the development of new antibacterial and antifungal agents. The company's platform uses a technology called ReBACS (Recombinant Biotechnology Assisted Combinatorial Synthesis) which offers a complex and rich structural diversity, enabling scientists to simplify the synthetic challenge in drug discovery and increases the probability of generating new lead compounds.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • PO Box 10
  • Alberton, MT 59820
  • United States
+1 (406) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Promiliad Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC Completed Generating Revenue
6. Grant 04-Apr-2019 00.000 Completed Generating Revenue
5. Grant 01-Jul-2013 00000 Completed Generating Revenue
4. Grant 01-Jul-2011 00.000 Completed Generating Revenue
3. Grant 15-Jul-2009 00000 Completed Generating Revenue
2. Grant 01-Jan-2006 $2.56M Completed Startup
1. Grant 15-Jul-2005 $474K Completed Startup
To view Promiliad’s complete valuation and funding history, request access »

Promiliad Executive Team (3)

Name Title Board Seat Contact Info
Priestley Nigel Co-Founder, Owner & Chief Executive Officer
Stephen Bergmeier Ph.D Co-Founder, Chief Operating Officer & Director, Medicinal Chemistry
Mark McMills Ph.D Co-Founder & CSO
To view Promiliad’s complete executive team members history, request access »

Promiliad Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Promiliad Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
TechGROWTH Ohio Not-For-Profit Venture Capital Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
To view Promiliad’s complete investors history, request access »